The effectiveness of vinorelbine plus cisplatin versus gemcitabine plus cisplatin in local advanced non-small cell lung cancer

被引：0
|
作者：
Koemuercueoglu, B. [1 ]
Aydogan, H. [1 ]
Tekguel, S. [1 ]
Cecen, E. [1 ]
Yalniz, E. [1 ]
Oezden, E. Pala [1 ]
机构：
[1] Izmir Res & Training Hosp Chest Dis & Surg, Izmir, Turkey
来源：
LUNG CANCER | 2006年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in the treatment of advanced non-small cell lung cancer (NSCLC).
    Zhang, Y
    Zhang, L
    Li, N
    Xu, F
    Pan, ZK
    Guang, ZZ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 702S - 702S
  • [2] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small cell lung cancer: A phase III randomized trial
    Georgoulias, V.
    Ardavanis, A.
    Tsiafaki, X.
    Agelidou, A.
    Syrigos, K.
    Polyzos, A.
    Kakolyris, S.
    Kouroussis, Ch
    Androulakis, N.
    Chatzidaki, D.
    ANNALS OF ONCOLOGY, 2004, 15 : 169 - 169
  • [3] Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations
    Hughes, DA
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1655 - 1655
  • [4] Efficacy and Safety of 8 spheres Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Locally Advanced Non-small Cell Lung Cancer
    Wang, Xiaojun
    Zhang, Huiyun
    Zhou, Liangfen
    Ou, Hui
    Liu, Hengyu
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2023, 38 (05) : 313 - 321
  • [5] CLINICAL EFFICACY OF VINORELBINE PLUS CISPLATIN IN ADVANCED NON-SMALL CELL LUNG CANCER
    童茂荣
    夏锡荣
    曹鄂洪
    施毅
    赵蓓蕾
    Chinese Journal of Cancer Research, 1996, (03) : 74 - 76
  • [6] Cisplatin plus vinorelbine chemotherapy for non-small cell lung cancer
    Pereira, JR
    Gampel, O
    Martins, SJ
    Ikari, FK
    Nikaedo, SM
    Paschoalini, M
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 643 - 646
  • [7] Gemcitabine plus docetaxel for advanced or metastatic non-small cell lung cancer: Similar survival to cisplatin plus vinorelbine and less toxicity
    Solomon, B
    Bunn, PA
    CANCER TREATMENT REVIEWS, 2005, 31 (07) : 571 - 576
  • [8] A cost effectiveness analysis of bevacizumab plus cisplatin and gemcitabine (BCG) versus cetuximab plus vinorelbine and cisplatin (CVC) in patients with advanced or recurrent non-small cell cancer (NSCLC) in Spain
    Castro Carpeno, Javier D.
    Castro Gomez, Antonio J.
    Walzer, Stefan
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S670 - S670
  • [9] Cost-effectiveness of Gemcitabine (Gemzar™) plus cisplatin versus etoposide plus cisplatin for advanced non small cell lung cancer (NSCLC) in Spain
    Rosell, R
    Sacristan, JA
    Duthie, T
    Cardenal, F
    Artal, A
    Carrato, A
    Lomas, M
    Barneto, I
    Bameto, I
    Massuti, B
    ANNALS OF ONCOLOGY, 1998, 9 : 92 - 93
  • [10] Gemcitabine/vinorelbine/cisplatin in patients with advanced non-small cell lung cancer
    Doweik, L
    Pohl, G
    Malayeri, R
    Krajnik, G
    Minar, W
    Pirker, R
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 263 - 266
12345